Recherche
Résultats 11-20 de 188
-
Surgery in reference centers improves survival of sarcoma patients: a nationwide study
Annals of oncology . official journal of the European Society for Medical Oncology, 05-06-2019, 30 (7), 1143-1153Article dans une revue scientifiquetexte intégral -
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
The Lancet. Oncology, 20-03-2018Article dans une revue scientifique -
Use of pd-1 targeting, macrophage infiltration, and ido pathway activation in sarcomas a phase 2 clinical trial
JAMA oncology, 01-01-2018, 4, 93-97Article dans une revue scientifique -
Activity and safety of palbociclib in patients with advanced gastrointestinal stromal tumors refractory to imatinib and sunitinib: a biomarker-driven phase 2 study
Clinical cancer research . an official journal of the American Association for Cancer Research, 12-04-2019Article dans une revue scientifique -
Comparison of response evaluation criteria in solid tumours and choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysis
European journal of cancer (Oxford, England . 1990), 01-01-2015, 51, 202-209Article dans une revue scientifique -
Regosarc: regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-a quality-adjusted time without symptoms of progression or toxicity analysis
Cancer, 15-06-2017, 123, 2294-2302Article dans une revue scientifiquetexte intégral -
Circulating vascular endothelial growth factor (vegf) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase ii trial of the french sarcoma group (gsf/geto)
Oncotarget, 08-11-2016, 7, 73984-73994Article dans une revue scientifiquetexte intégral -
An update on the management of sporadic desmoid-type fibromatosis: a european consensus initiative between sarcoma patients euronet (spaen) and european organization for research and treatment of cancer (eortc)/soft tissue and bone sarcoma group (stbsg)
Annals of oncology . official journal of the European Society for Medical Oncology, 01-10-2017, 28, 2399-2408Article dans une revue scientifiquetexte intégral -
Dose-seeking phase i trials for currently approved molecular-targeted therapies in the usa: the dose-limiting toxicity definition issue
Pharmaceutical medicine, 01-06-2016, 30, 143-147Article dans une revue scientifique -
First-line management of metastatic castrate-resistant prostate cancer patients: audit of real-life practices
Bulletin du cancer, 01-06-2017, 104, 552-558Article dans une revue scientifique